Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ETTX - Entasis Therapeutics: AstraZeneca Spin-Out Developing Targeted Antibacterial Products

ETTX - Entasis Therapeutics: AstraZeneca Spin-Out Developing Targeted Antibacterial Products

Entasis Therapeutics Holdings Inc.
  • Entasis Therapeutics is a clinical stage biopharmaceutical company developing targeted antibacterial products against multidrug resistant pathogens.
  • The Company was spun-out in 2015 as a wholly owned subsidiary of AstraZeneca.
  • The Company recently announced positive topline results from the phase 3 trial of its lead candidate, SUL-DUR.

For further details see:

Entasis Therapeutics: AstraZeneca Spin-Out Developing Targeted Antibacterial Products
Stock Information
Company Name: Entasis Therapeutics Holdings Inc.
Stock Symbol: ETTX
Market: NASDAQ
Website: entasistx.com
Menu
ETTX ETTX Quote ETTX Short ETTX News ETTX Articles ETTX Message Board
Get ETTX Alerts

News, Short Squeeze, Breakout and More Instantly...